Early Colon Cancer Detected by 18F-FDG PET
- 1 January 2005
- journal article
- case report
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 36 (2) , 95-98
Abstract
Positron emission tomography (PET) is a noninvasive functional imaging modality that can disclose the presence of a malignant disease. It has recently been reported that PET may be useful to detect primary colorectal cancer (CRC). We present the case of a 47-yr-old man with early colon cancer detected by 18F-fluorodeoxyglucose (FDG) PET. The patient consulted us because of a positive fecal occult blood test and focal FDG uptake in the pelvic cavity detected at a physical check-up. After the usual work up, he was diagnosed as having a sigmoid polyp, 16 mm in diameter. Subsequently, colonoscopic polypectomy was carried out. The surgical specimen was histologically diagnosed as a well-differentiated adenocarcinoma, invading the submucosal layer with lymphatic invasion. Therefore, the involved portion of the sigmoid colon was laparoscopically resected. The FDG PET carried out 1 yr after the operation, showed no abnormal FDG uptake. PET can noninvasively detect an early colon cancer as small as in our patient, as well as other cancers in the whole body. Therefore, we consider it suitable as a screening examination.Keywords
This publication has 18 references indexed in Scilit:
- Early colon cancers detected by FDG-pet: a report of two cases with immunohistochemical investigation.2004
- The role of positron emission tomography in the management of colorectal cancerColorectal Disease, 2003
- Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan.2003
- Incidental Colonic Fluorodeoxyglucose Uptake: Correlation with Colonoscopic and Histopathologic FindingsRadiology, 2002
- The impact of FDG-PET on the management algorithm for recurrent colorectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PETClinical Positron Imaging, 1999
- Utility of FDG-PET for Investigating Unexplained Plasma CEA Elevation in Patients With Colorectal CancerAnnals of Surgery, 1998
- Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.Radiology, 1998
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Use of positron emission tomography in oncology.1993